Stay updated on Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial
Sign up to get notified when there's something new on the Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial page.

Latest updates to the Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page history shows a new revision entry v3.3.2 and removes v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedRemoved the government funding/operating status notice from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check42 days agoChange DetectedRecord history shows updates to Study Status and Recruitment Status across multiple versions, with changes to Contacts/Locations. These entries reflect ongoing monitoring of the trial’s progress and point of contact information.SummaryDifference0.1%

- Check71 days agoChange DetectedCore content updated: new government funding and operating status notice plus a v3.2.0 release; previous v3.1.0 tag removed.SummaryDifference12%

- Check78 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.3%

- Check92 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2. The 'Back to Top' link was removed.SummaryDifference0.7%

Stay in the know with updates to Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial page.